Semaglutide Recalls
6 official U.S. semaglutide recalls on record from FDA. The most recent was announced 2026-04-22 (PAYLESS COMPOUNDERS, LLC). Brands involved include PAYLESS COMPOUNDERS, LLC, Harbin Jixianglong Biotech Co., Ltd., New Life Pharma LLC, Novo Nordisk Inc., ProRx LLC, Boothwyn Pharmacy LLC. Open any record for the affected lots and what to do.
| Date | Recall | Brand | Agency |
|---|---|---|---|
| 2026-04-22 | Semaglutide Recall: Northwest Compounders Lot 01-27-2026@14S.5 | PAYLESS COMPOUNDERS, LLC | FDA |
| 2026-03-11 | Semaglutide Recall: Harbin Jixianglong Biotech CP-030-20250711 | Harbin Jixianglong Biotech Co., Ltd. | FDA |
| 2026-03-11 | Semaglutide Recall: Nomida Lot 241113 and Lot 250103 | New Life Pharma LLC | FDA |
| 2026-01-07 | Semaglutide Recall: Wegovy Injection Pens | Novo Nordisk Inc. | FDA |
| 2025-11-05 | Semaglutide Recall: ProRx 2 mL Multidose Vial | ProRx LLC | FDA |
| 2025-09-10 | Semaglutide Recall: Boothwyn Pharmacy 2.5 mg/mL injection | Boothwyn Pharmacy LLC | FDA |
Each record is built from the official notice and links to it. Recalls of other products are in the Recall Database.